Skip to content

POELMAN

Active
Private limited companyfounded 198540 yrs activeStaatsbaan 128D, 3945 Tessenderlo-Ham, BelgiumKBO/BCE: BE 0428.334.479
Summary

POELMAN has been active since 1985 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €65,390 and a net result of €29,776. Equity is growing by ~10.8% per year across the filed fiscal years. Its solvency ranks better than 20% of 10645 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisWatch ReportCompare
POELMANActiveChecked score 56/100
Risk analysis ReportCompare

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
1 site
How big
€709,941total assets 2025
Staff
2.1 FTE
Equity
€65,390
Profit
€29,776
Turnover not published (abridged schema)
Financially healthy?
56 Fair Checked score 2025
Bankruptcy chance 12 m
0.4%
Who decides
Parent
DE VIS · 99.2%
Accounts 53 d early0 of 2 deeds read
Why 56- Higher-failure-rate sector- Weak solvency vs sector+ Long track record+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence

Checked score

Score 2025
56 / 100
Fair
Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-8
Solvency34▼-1
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3,500 at 30 days acceptable
Liquidity short (current ratio 0.77 against 0.84 in 2024; short-term debt: 71.1% and cash: 9.4% of total assets), and 90.8% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 40 years 0 50 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
9.2%
Return on assets
4.2%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 10645 sector peers (2025).
NBB · sector comparison
Position among 10645 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
53 d early
2024
28 d late
2023
26 d late
2022
62 d early
2021
61 d early
2020
60 d early
2019
50 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 8 June (4 of the last 5 filed years within 80 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Weakest financial yearnet €29,776 ▼55.5%
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Caution: Among the weakest 20% on solvencysector median 37.1% · 10,645 companies 9.2% View
  • Positive: 8 profitable years in a rowprofit 2025: €29,776 8 years View
  • Controlled by DE VIS 99.2% View

By topic

Financials

Fiscal year
2025
Total assets
€709,941
Profit
€29,776
Solvency
9.2%
Total assets▲ 14.7%
Net result
20182025
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 31-07-2027
  1. 08-06-2026Annual accounts filed
  2. 31-12-2025Weakest financial year
  3. 28-08-2025Annual accounts filed
Go to Timeline

Support & recognitions

Funding sources
1
Recognitions
1 register
Flemish government
€2,530awarded · 2025
FASFC
1authorised site
Go to Support & recognitions

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
27-12-1985
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure